Fetal death of unspecified cause

P16_FETAL_DEATH_UNSP_CAUSE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P95 Cause of death: ICD-10 — P95 2 out of 7 registries used, show all original rules.	66
4. Check minimum number of events None	66
5. Include endpoints None	66
6. Filter based on genotype QC (FinnGen only)	60

Control definitions (FinnGen only)

Control exclude: P16_OTH_DISORD_ORIGINA_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P9
Name in latin: Mors fetus causa non specificata

NAME	P16_FETAL_DEATH_UNSP_CAUSE
CONTROL_EXCLUDE	P16_OTH_DISORD_ORIGINA_PERINA_PERIOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P95
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P95
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fetal death of unspecified cause based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	391	384	-
Only index persons	380	378	-
Unadjusted period prevalence (%)
Whole population	0.01	0.01	-
Only index persons	0.01	0.01	-
Median age at first event (years)
Whole population	31.05	31.27	-
Only index persons	31.20	31.27	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	60	60	-
Unadjusted period prevalence (%)	0.02	0.02	-
Median age at first event (years)	31.78	31.78	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
60: Matched controls
600

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P95

ICD-10 Finland

Fetal death of unspecified cause

+∞

86.1

G02CB01

ATC

bromocriptine; systemic

31.8

19.0

O36.4

ICD-10 Finland

Maternal care for intrauterine death

77.3

15.7

Z39.2

ICD-10 Finland

Routine postpartum follow-up

7.8

14.5

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

6.6

11.8

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

17.7

11.0

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

11.7

8.7

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.25

2.33

1.6

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4.04

1.99

2.7

3.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.33

1.90

2.9

2.7

8.13

132.56

ng/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

4.44

1.86

2.0

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

4.44

1.86

2.0

1.2

—

(3013512) EKG study

122

1.96

1.52

4.1

2.5

—

(4035726) Immunohistochemistry procedure

2.34

1.41

1.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

1.40

0.0

1.1

—

1.67

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

1.40

0.0

1.1

—

0.88

—

(3003694) ABO and Rh group [Type] in Blood

151

0.46

1.39

3.0

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2.34

1.27

18.0

4.8

248.88

232.97

u/l

—

(3042936) Bacteria identified in Isolate by Culture

2.10

1.21

3.5

2.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

319

1.76

1.21

4.4

3.6

—

17.40

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.27

1.10

1.1

1.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2.27

0.94

20.8

5.2

1.27

1.67

mmol/l

—

(3017732) Neutrophils [#/volume] in Blood

1.83

0.93

6.3

3.8

3.88

4.24

e9/l

0.18

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.04

0.87

3.2

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

158

0.56

0.86

9.2

5.4

—

(3035350) Ketones [Presence] in Urine by Test strip

285

1.55

0.85

3.4

3.1

0.00

estimate

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

142

0.57

0.83

3.0

1.8

115.33

126.43

u/l

—

136

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.77

0.82

3.4

4.3

4.38

4.88

pmol/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

358

1.58

0.81

4.5

3.7

—

(3009261) Glucose [Presence] in Urine by Test strip

288

1.52

0.78

3.5

3.1

0.00

estimate

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2.28

0.78

3.8

3.2

71.30

68.22

g/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

137

1.57

0.77

3.3

1.2

2.26

2.13

g/l

0.08

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.18

0.76

2.0

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

193

1.51

0.75

5.6

4.4

37.90

37.24

g/l

0.32

188

(46235355) HIV 1 and 2 tests - Meaningful Use set

138

1.55

0.75

2.1

—

(3000991) Gas panel - Venous blood

2.00

0.72

29.4

6.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

462

1.69

0.71

3.9

3.7

—

(3022145) Colonoscopy Study observation

1.74

0.70

1.2

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

114

1.55

0.68

2.5

3.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

197

1.46

0.67

3.0

22.80

25.81

u/l

0.71

190

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

488

1.74

0.66

18.5

14.5

331.34

331.68

g/l

0.09

488

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.73

0.65

3.3

1.9

—

(40768804) Tissue Pathology biopsy report

243

0.68

0.63

2.6

2.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1.62

0.62

1.4

1.6

1672.00

1068.20

nmol/l

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

0.53

0.62

4.8

2.1

2.49

2.41

mmol/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.85

0.61

3.3

1.8

—

(3019225) pH of Specimen

1.74

0.59

2.5

5.5

7.37

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

127

1.47

0.58

1.9

1.8

—

(3023368) Bacteria identified in Blood by Culture

1.53

0.56

7.3

3.6

—

(3021589) Normoblasts [#/volume] in Blood

228

0.70

0.55

31.7

9.4

0.01

0.00

e9/l

0.65

184

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.60

0.55

22.2

5.6

104.33

105.03

mmol/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

285

1.35

0.48

3.6

3.1

0.00

estimate

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.45

0.47

5.3

3.8

30.57

30.95

—

(21494755) Public health laboratory ask at order entry panel

1.45

0.44

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

1.44

0.44

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.61

0.43

2.4

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

113

0.66

0.42

1.3

2.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.40

0.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.40

0.0

1.1

—

(3026008) Bacteria identified in Urine by Culture

117

1.38

0.40

2.1

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.36

0.39

2.4

1.8

—

(3002256) Pathology report gross observation

0.64

0.38

1.6

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.42

0.37

1.8

1.9

—

(1002224) Polysomnography panel

1.37

0.35

1.0

1.1

—

(3015736) pH of Urine

235

1.27

0.34

2.9

2.8

6.20

6.10

0.20

148

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

106

0.72

0.32

4.8

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

201

0.78

0.30

2.6

1.8

98.00

98.85

pmol/l

0.04

120

(42870588) Differential panel, method unspecified - Blood

162

1.25

0.27

14.5

6.4

—

(40758558) Short blood count panel - Blood

153

1.25

0.26

17.4

6.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

156

0.79

0.25

1.6

1.3

51.54

26.57

iu/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

154

1.24

0.25

2.9

3.0

0.00

estimate

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

509

1.35

0.24

4.2

3.8

5.62

5.61

mmol/l

0.02

481

(3010421) pH of Blood

0.00

0.21

0.0

2.0

—

7.45

—

(44806420) Estimation of glomerular filtration rate

0.00

0.21

0.0

2.1

—

(3035715) Granulocytes [#/volume] in Blood

0.00

0.21

0.0

4.3

—

4.62

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.21

0.0

1.7

—

7.15

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

2.1

—

10.19

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

3.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

2.1

—

5.02

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.20

0.0

3.9

—

60.14

—

(3010813) Leukocytes [#/volume] in Blood

586

+∞

0.20

32.6

18.2

6.45

6.54

e9/l

0.15

578

(3026361) Erythrocytes [#/volume] in Blood

586

+∞

0.20

32.5

18.1

4.48

e12/l

0.00

579

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.20

0.20

1.7

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

246

1.18

0.19

4.0

2.6

69.23

72.36

nmol/l

0.20

233

(3001122) Ferritin [Mass/volume] in Serum or Plasma

326

1.18

0.19

4.2

3.3

66.45

65.75

ug/l

0.02

313

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.23

0.19

5.9

2.3

2.38

2.47

g/l

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.19

0.18

2.6

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.19

0.18

2.1

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

534

1.36

0.18

4.5

4.2

1.51

1.57

mmol/l

0.63

513

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

129

0.82

0.16

2.9

1.9

3.64

2.64

mg/l

0.84

115

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.76

0.15

1.7

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

506

1.21

0.15

4.1

3.6

1.22

1.23

mmol/l

0.08

482

(3022096) Basophils/Leukocytes in Blood

258

0.88

0.12

16.5

6.2

0.57

0.69

0.59

243

(1761868) Lipid panel - Serum or Plasma

288

0.89

0.12

2.9

2.7

—

(3019069) Monocytes/Leukocytes in Blood

257

0.89

0.11

16.5

6.2

8.66

8.29

0.23

245

(3013115) Eosinophils [#/volume] in Blood

296

0.90

0.10

15.7

6.6

0.12

0.19

e9/l

3.91

273

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

146

1.13

0.09

1.4

1.3

5.47

6.41

u/ml

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

265

1.11

0.09

8.2

6.7

11.55

9.57

umol/l

0.56

256

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.06

0.09

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

536

1.31

0.08

26.4

11.9

17.69

16.99

mg/l

0.08

413

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

137

1.13

0.08

6.5

2.9

34.40

11.83

ng/l

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

0.84

0.08

9.5

2.6

0.86

0.83

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.80

0.08

3.2

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

427

1.11

0.08

4.3

3.1

29.82

34.48

u/l

0.57

420

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

177

1.11

0.08

1.7

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

519

1.18

0.07

26.4

10.4

139.85

139.88

mmol/l

0.03

509

(3023103) Potassium [Moles/volume] in Serum or Plasma

520

1.16

0.07

27.2

10.5

3.90

3.89

mmol/l

0.08

508

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1.08

0.07

1.3

1.6

489.44

468.37

pmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.87

0.07

3.3

1.5

1.38

1.25

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

507

1.19

0.07

24.2

9.9

92.08

91.21

ml/min/173m2

0.13

464

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

148

1.11

0.07

4.3

2.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

479

1.13

0.06

5.6

4.6

37.59

37.12

mmol/mol

0.12

468

(3001604) Monocytes [#/volume] in Blood

282

0.92

0.06

15.5

6.4

0.51

0.52

e9/l

0.10

254

(3006315) Basophils [#/volume] in Blood

282

0.92

0.06

15.2

6.4

0.04

e9/l

0.08

252

(3044640) Blood type and Crossmatch panel - Blood

149

1.10

0.06

3.6

2.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

161

1.08

0.03

6.2

2.3

47.59

55.13

u/l

0.52

156

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

169

0.93

0.03

1.8

1.6

—

(3018010) Neutrophils/Leukocytes in Blood

261

1.06

0.03

15.4

6.0

54.34

56.27

0.44

251

(3006504) Eosinophils/Leukocytes in Blood

258

0.95

0.02

15.8

6.1

2.18

2.89

1.87

246

(3002030) Lymphocytes/Leukocytes in Blood

262

1.06

0.02

14.9

6.2

33.31

29.76

1.23

253

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

224

1.04

0.00

16.1

5.2

1.21

mmol/l

0.17

195

(3019198) Lymphocytes [#/volume] in Blood

291

0.99

0.00

14.7

6.4

1.96

1.92

e9/l

0.13

269

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

227

1.02

0.00

3.8

2.7

—

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

105

0.94

0.00

1.4

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

455

0.96

0.00

5.1

5.0

13.56

14.21

pmol/l

1.12

442

(3015377) Calcium [Moles/volume] in Serum or Plasma

182

0.98

0.00

4.2

3.3

2.38

2.34

mmol/l

0.88

172

(36304419) Bacteria [Presence] in Urine

108

1.02

0.00

5.0

2.2

—

estimate

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

112

0.98

0.00

1.2

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

-0.00

0.0

6.7

—

1.31

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

8.92

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.5

—

90.78

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

0.00

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.5

—

100.33

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(40768797) Stomach Pathology biopsy report

0.88

-0.00

1.1

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

17.6

—

1664.29

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

516

1.06

-0.00

5.7

5.8

1.65

1.71

mu/l

0.18

500

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

69.33

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.5

—

58.83

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

0.00

—

(3000492) Spirometry study

0.93

-0.00

1.3

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

4.5

—

40.17

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.54

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

0.91

-0.00

2.7

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

130

1.00

-0.00

5.7

2.5

7.22

8.04

mmol/l

0.25

113

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

13.0

—

0.68

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.4

—

7.93

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

-0.00

0.0

8.2

—

3.76

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

51.80

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.6

—

944.29

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

-0.00

0.0

1.6

—

16.87

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_FETAL_DEATH_UNSP_CAUSE and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_FETAL_DEATH_UNSP_CAUSE.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_FETAL_DEATH_UNSP_CAUSE – Fetal death of unspecified cause

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Fetal death of unspecified cause

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints